Literature DB >> 7246158

[Identification of cardiac glycosides from the seeds of Descurainia sophia L. Webb (author's transl)].

Y Q Chen, R Z Li, Y W Wang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7246158

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN： 0513-4870


× No keyword cloud information.
  5 in total

1.  Optimization of supercritical fluid extraction of essential oils and fatty acids from flixweed (Descurainia Sophia L.) seed using response surface methodology and central composite design.

Authors:  Katayoun Mahdavi Ara; Mina Jowkarderis; Farhad Raofie
Journal:  J Food Sci Technol       Date:  2015-03-07       Impact factor: 2.701

2.  Effect of an ethanol extract of Descurainia sophia seeds on Phase I and II drug metabolizing enzymes and P-glycoprotein activity in vitro.

Authors:  Jin-Mu Yi; Young Ah Kim; You Jin Lee; Ok-Sun Bang; No Soo Kim
Journal:  BMC Complement Altern Med       Date:  2015-12-18       Impact factor: 3.659

3.  Determination of the volatile composition in essential oil of Descurainia sophia (L.) Webb ex Prantl (Flixweed) by gas chromatography/mass spectrometry (GC/MS).

Authors:  Jing Li; Xingang Liu; Fengshou Dong; Jun Xu; Yongquan Zheng; Weili Shan
Journal:  Molecules       Date:  2010-01-08       Impact factor: 4.411

4.  Helveticoside is a biologically active component of the seed extract of Descurainia sophia and induces reciprocal gene regulation in A549 human lung cancer cells.

Authors:  Bu-Yeo Kim; Jun Lee; No Soo Kim
Journal:  BMC Genomics       Date:  2015-09-18       Impact factor: 3.969

5.  Gene Expression Profile of the A549 Human Non-Small Cell Lung Carcinoma Cell Line following Treatment with the Seeds of Descurainia sophia, a Potential Anticancer Drug.

Authors:  Bu-Yeo Kim; Jun Lee; Sung Joon Park; Ok-Sun Bang; No Soo Kim
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-27       Impact factor: 2.629
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.